Metasphere Labs Inc.
LABZF
$0.0502
-$0.0062-10.99%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -96.72% | -- | -52.40% | 166,000.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -96.72% | -- | -52.40% | 166,000.00% |
| Cost of Revenue | -- | -78.99% | -- | -47.10% | 426.44% |
| Gross Profit | -- | -99.78% | -- | -53.26% | 2,463.95% |
| SG&A Expenses | -36.33% | 11.37% | 22.61% | -20.81% | -13.90% |
| Depreciation & Amortization | -- | -- | -- | -10.66% | -51.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -55.85% | -37.92% | -15.77% | -18.84% | -0.63% |
| Operating Income | -272.17% | -121.04% | -180.59% | -82.59% | 125.50% |
| Income Before Tax | -201.46% | -121.32% | -200.46% | 26.24% | 107.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -201.46% | -121.32% | -200.46% | 26.24% | 107.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -201.46% | -121.32% | -200.46% | 23.97% | 107.17% |
| EBIT | -272.17% | -121.04% | -180.59% | -82.59% | 125.50% |
| EBITDA | -229.71% | -119.48% | -174.21% | -185.63% | 133.12% |
| EPS Basic | -202.70% | -108.64% | -105.37% | 94.76% | 100.32% |
| Normalized Basic EPS | -300.00% | -111.01% | -105.72% | 91.78% | 100.82% |
| EPS Diluted | -359.26% | -112.84% | -106.64% | 94.76% | 100.23% |
| Normalized Diluted EPS | -366.67% | -119.35% | -105.72% | 91.78% | 100.62% |
| Average Basic Shares Outstanding | -0.83% | 145.97% | 1,767.41% | 1,349.13% | 2,129.75% |
| Average Diluted Shares Outstanding | -29.42% | 39.89% | 1,767.41% | 1,349.13% | 3,033.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |